Liminatus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Liminatus Pharma Inc.: Is Infosys Ltd. worth buying?
Item: Liminatus Pharma Inc.
Rating: 0.30875
Author: Trendlyne DVM scores

about

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, ga...

0.16 -0.02 (-11.11%)

99.52% Fall from 52W High

4.2M

XNAS Volume

XNAS 29 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Liminatus Pharma Inc is on 02 Jun 2026 for the purpose of Liminatus Pharma Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

12.4 / 100

No estimates available

Liminatus Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Liminatus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, ga...

99.52% Fall from 52W High

SWOT Analysis

Liminatus Pharma Inc Live Price Chart